I 100% Agree, I don't think our psychedelics trial has been factored into our current share price at all. I also believe we should be trading above 20c even without that announcement a few weeks ago regarding GAD. Our other trials are mind bobblingly huge, SAARDS alone which is what I'm most excited about should have us above 20c.
I haven't followed much in the world of psychotherapy I invested in this company for what we were already developing in regards to Sleep Apnea, Concussion, Oils and SAARDS. Most of the info and knowledge I have about this field is from people in this chat sharing their knowledge. The psychedelics trial is an absolute bonus and will be a massive value injector into the company on its own. I agree, post New Years we should see a steady climb upwards as more and more people begin to grasp what we are doing and achieving.
- Forums
- ASX - By Stock
- IHL
- General discussion
General discussion, page-3465
-
-
- There are more pages in this discussion • 16,531 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)